Calcium Modulation and Clinical Effect H. Timmerman Introductory Lecture 22 November 2012 Pages: 1 - 4
The Contribution of Haemorheology to the Understanding of Microcirculatory Disorders P. Teitel Introductory Lecture 22 November 2012 Pages: 5 - 11
Microcirculation and Neurotransmitter Metabolism in the Pathophysiology of Brain Ischaemia M. S. MagnoniS. GovoniM. Trabucchi Introductory Lecture 22 November 2012 Pages: 12 - 18
Primary and Secondary Blood Hyperviscosity Syndromes, and Syndromes Associated with Blood Hyperviscosity Sandro ForconiD. PieragalliR. Cappelli Introductory Lecture 22 November 2012 Pages: 19 - 26
Influence of Cyclandelate on In Vitro Red Blood Cell Deformability D. W. R. HallW. E. van den Hoven Section 1: Pharmacological Studies: Modes and Mechanisms of Action 22 November 2012 Pages: 30 - 40
Inhibition of Human Platelet Functions by Cyclandelate W. E. van den HovenD. W. R. Hall Section 1: Pharmacological Studies: Modes and Mechanisms of Action 22 November 2012 Pages: 41 - 52
The Influence of Cyclandelate on Ca++ Translocation in Human Platelets J. W. N. AkkermanW. E. van den Hoven Section 1: Pharmacological Studies: Modes and Mechanisms of Action 22 November 2012 Pages: 53 - 59
Effect of Cyclandelate on Prostacyclin Release and Cytosolic Free Calcium Concentrations in Human Endothelial Cells V. W. M. van Hinsbergh Section 1: Pharmacological Studies: Modes and Mechanisms of Action 22 November 2012 Pages: 60 - 66
Cyclandelate as a Calcium Modulating Agent in Rat Cerebral Cortex A. BastR. LeursH. Timmerman Section 1: Pharmacological Studies: Modes and Mechanisms of Action 22 November 2012 Pages: 67 - 74
Cyclandelate Bruce MiddletonFrancesca CacciaguerraDavid White Section 1: Pharmacological Studies: Modes and Mechanisms of Action 22 November 2012 Pages: 75 - 79
Discussion Section 1 H. Timmerman Section 1: Pharmacological Studies: Modes and Mechanisms of Action 22 November 2012 Pages: 80 - 81
The Memory Clinic Antony J. BayerM. S. John PathyCharles Twining Section 2: Clinical Studies 22 November 2012 Pages: 84 - 89
Cyclandelate versus Flunarizine M. G. AlbizzatiS. BassiL. Frattola Section 2: Clinical Studies 22 November 2012 Pages: 90 - 96
Specific Effects of Cyclandelate on Memory Jambur Ananth Section 2: Clinical Studies 22 November 2012 Pages: 97 - 102
Comparative Efficacy of Cyclandelate versus Flunarizine in the Prophylactic Treatment of Migraine G. NappiG. SandriniG. Micieli Section 2: Clinical Studies 22 November 2012 Pages: 103 - 109
Cyclandelate in the Treatement of Multi-Infarct Dementia C. B. Blakemore Section 2: Clinical Studies 22 November 2012 Pages: 110 - 113
Cyclandelate in the Treatment of Vertigo of Circulatory Origin F. de Halleux Section 2: Clinical Studies 22 November 2012 Pages: 114 - 119
Perceived Efficacy of Cyclandelate in the Treatment of Cochleovestibular and Retinal Disturbances Related to Cerebrovascular Insufficiency Y. Memin Section 2: Clinical Studies 22 November 2012 Pages: 120 - 124
Clinical Experience with Cyclandelate in Insulin-Dependent Diabetic Patients with Neuropathy I. H. De LeeuwP. Van RooyM. Driessens Section 2: Clinical Studies 22 November 2012 Pages: 125 - 130
The Effect of Cyclandelate on Cholesterol Metabolism in Patients with Familial Hypercholesterolaemia J. A. Gevers LeuvenH. v. d. VoortL. Havekes Section 2: Clinical Studies 22 November 2012 Pages: 131 - 135